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Acivicin inhibits y-glutamyl transpeptidase activity in human keratinocytes in culture. Treatment of these cells with acivicin produces a decrease 
in the uptake of L-[U-W]alanine. 2-amino-[1-WI-isobutyrate, L-[U-W]leucine and 1-aminocyclopentane-I-PQarboxylate. D-[U-‘4C&lucose 
uptake is not affected by the presence of acivicin. These results support, for the first time in vitro, the hypothesis that the y-glutamyl cycle may 
be involved in amino acid uptake by human cells. 
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1. INTRODUCTION 
The y-glutamyl cycle, which accounts for the biosyn- 
thesis and degradation of GSH, was proposed as a 
mechanism for amino acid uptake by cells [l]. This is 
supported by the fact that tissues rich in y-glutamyl 
transpeptidase (GGT) show high rates of amino acid 
uptake and that y-glutamyl amino acids are formed by 
the interaction of GGT with intracellular GSH and ex- 
tracellular amino acids [2]. y-Glutamyl amino acids are 
transported by a system not shared by free amino acids 
and are converted, inside the cells, to free amino acids 
and 5-oxoproline by the action of y-glutamyl 
cyclotransferase [3]. 
The hypothesis that the cycle is a mechanism for 
amino acid uptake has received serious criticisms. The 
bulk uptake of amino acids by yeast (Saccharomyces 
cerevisiae) is not related to GGT activity [4]. Recently, 
no relationship was found between GGT activity and 
amino acid uptake in the intestine of Atlantic salmon 
[5]. However, the possible role of GGT in amino acid 
uptake has received support in some tissues and under 
different experimental situations. For instance, in cere- 
bral endothelial cells, GGT activity was related to 
amino acid uptake [6] and, inhibition of GGT, resulted 
in a decreased utilization of glutamine in kidney cells in 
culture [7]. We showed that amino acid uptake by the 
lactating mammary gland is related to GGT activity [8]. 
To address the possibility of a role of this cycle in 
human cells, we measured the uptake of L-[U-14C]leu- 
tine, L-[U-14C]alanine, 2-amino-[1-i4C]isobutyric acid 
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and 1 -aminocyclopentane- 1 -[ 14C]carboxylic acid by 
isolated human keratinocytes when GGT activity was 
decreased by a specific inhibitor. We have selected this 
experimental model to study the y-glutamyl cycle in 
human cells because (i) the epidermal keratinocytes are 
one of the few human diploid cell types that grow well 
in culture, (ii) they present high GGT activity and (iii) 
when they are isolated from a primary culture and sus- 
pended in adequate incubation media, they show a 
linear uptake of amino acids, at least during the first 20 
min of incubation. In this paper, we show that inhibi- 
tion of GGT leads to a decrease in the uptake of amino 
acids, but not of glucose, by human keratinocytes. 
2. MATERIALS AND METHODS 
Human epidermal keratinocytes were cultivated according to 
Rheinwald and Green [9]. To obtain isolated cells, secondary cultures 
were trypsinized. The resulting cell suspension was centrifuged for 5 
min and resuspended in Krebs-Henseleit saline to a cell density of 2 
X lo6 cells/ml. 
Keratinocytes were preincubated at 37’C for 30 min in Krebs- 
Henseleit saline solution equilibrated with Oz/COs (19:1), or with the 
same saline solution containing 0.35 mM acivicin (o- 
amino-3-chloro-4,5-dihydro-S-isoxazoleacetic ac d) to inhibit GGT 
activity [lo]. 
After this preincubation, they were incubated for 10 or 20 min in 
2 ml of Krebs-Henseleit saline containing L-[U-‘4C]leucine, or L- 
[U-‘4C]alanine, or 2-amino-[1-r4C]isobutyric a id, a non-metabo- 
lizable analog of alanine, or 1-aminocyclopentane-l-[‘4C]-carboxylic 
acid (cycloleucine), a leucine analog, or D-[U-‘4C]glucose. 
Incubations were terminated by addition of 5 ml of ice-cold Krebs- 
Henseleit saline. After washing cells 3 times, amino acid or glucose 
uptake was determined measuring specific activity of each 
metabolite. 
GGT activity in the cells was estimated measuring spectrophoto- 
metrically the appearance of p-nitroaniline from y-glutamyl p- 
nitroanilide in presence of glycyl-glycine [1 I]. 
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Table I 
Effect of acivicin on GSH levels, -r-glutamyl transpeptidase (GGT) activity and glucose uptake in isolated human keratinocytes in culture 
GSH GGT activity Glucose uptake 
(nmol x 10e6 cells) (nmol PNA x 10e6 cells x min-‘) (nmol x IO-” cells) 
10 min 20 min 
Control 20.8 f 9.2 (3) 7.1 f 2.8 (3) 1.0 f 0.12 (3) 2.3 f 0.35 (3) 
Acivicin 21.4 f 10.4 (3) 3.0 f 1.0 (3)* 1.0 f 0.06 (3) 2.2 f 0.23 (3) 
PNA = p-nitroaniline. Glucose concentration in the suspension medium was 5 mM. Results are means f SE, with the numbers of observations 
in parentheses. Values that are significantly different from controls are shown: * PcO.05. 
Table II 
Effect of inhibition of y-glutamyl transpeptidase by acivicin on amino acid uptake in isolated human keratinocytes from secondary culture 
Leucine Cycloleucine Alanine AIB 
(nmol x 10m6 cells) 
Control 10 min 3.7 f 1.3 (3) 25.6 * 9.1 (3) 69.1 f 12.2 (3) 
20 min 7.2 f 2.2 (3) 35.7 f 14.4 (3) 138.1 f 33.5 (3) 7.6 + 1.4 (6) 
Acivicin 10 min 2.6 f 1.0 (3): 15.5 f 5.4 (3) 42.8 f 7.6 (3) 
20 min 5.0 f 1.6 (3)* 21.2 f 10.2 (3)’ 81.4 f 10.6 (3)* 5.3 f 0.8 (6)* 
AIB = 2-amino isobutyric acid. Cycloleucine = l-aminocyclopentane-I-carboxylic a id. The concentration of amino acids or their analogs was 
1 mM. Results are means rt SE, with the numbers of observations in parentheses. Values that are significantly different from controls are shown: 
*Pco.os. 
3. RESULTS AND DISCUSSION 
Table I shows that addition of 0.35 mM acivicin to 
isolated human keratinocytes resulted in a 53% de- 
crease in y-glutamyl transpeptidase activity. This is in 
agreement with previous findings in other organs which 
showed that acivicin is a good inhibitor of GGT [12]. 
Inhibition of GGT has no effect on D-[U-‘4C]glucose 
uptake by isolated human keratinocytes after 10 or 20 
min of incubation (Table I). 
We have studied the uptake of physiological amino 
acids and of their analogs by isolated human keratino- 
cytes. Table II shows that the uptake of L-[U-14C]- 
leucine or of 1 -aminocyclopentane-1 -[ “C]carboxylic 
acid (cycloleucine), which are transported inside the 
cells mainly by the L system, were significantly lower in 
keratinocytes incubated with acivicin than in controls. 
Table II also shows that the uptake of L-[U-14C]alanine 
or of 2-amino-[l-‘4C]isobutyric acid, which can be car- 
ried by two systems (A and ASC), was also significantly 
lower in keratinocytes incubated with acivicin than in 
controls. 
All our previous experiments on the involvement of 
the y-glutamyl cycle on amino acid uptake had been 
carried out in vivo. In lactating mammary gland, we 
have shown that this cycle is involved in amino acid 
translocation by measuring arterio-venous differences 
of amino acids across the gland under different ex- 
perimental conditions [8,13]. In pregnant rats, inhibi- 
tion (79%) of placental GGT activity by acivicin results 
in a 50% decrease in placental transfer of L-[U-‘4C]- 
alanine and a 70-80% decrease in its incorporation into 
the placental and fetal proteins [14]. Recently, we have 
proposed that the y-glutamyl cycle may not be an 
amino acid transport system, but rather a mechanism 
to generate a signal that activates either amino acid up- 
take by the conventional systems for amino acid trans- 
port [15,16] or amino acid metabolism. Furthermore, 
we have provided some evidence showing that y-gluta- 
my1 amino acids and/or oxoproline may be such signals 
]161. 
Results reported in this paper support the hypothesis 
that the y-glutamyl cycle is involved in amino acid 
transport in human cells. These results are compatible 
with the idea [16] that the cycle is not a system for 
amino acid transport, but rather a mechanism for the 
control of amino acid uptake by systems like the L, the 
A or the ASC that we have tested here. 
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